Site-specific mesenchymal control of inflammatory pain to yeast challenge in vulvodynia-afflicted and pain-free women

Pain

Volumn 156, Issue 3, 2015, Pages 386-396

  Foster, David C ^a   Falsetta, Megan L ^b   Woeller, Collynn F ^b   Pollock, Stephen J ^b   Song, Kunchang ^b   Bonham, Adrienne ^a   Haidaris, Constantine G ^b   Stodgell, Chris J ^a   Messing, Susan P ^c   Iadarola, Michael ^d   Phipps, Richard P ^b  

^a STRONG MEMORIAL HOSPITAL   (United States)

^b Department of Environmental Medicine ^*  (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Fibroblast heterogeneity; Localized provoked vulvodynia; Vestibulodynia; Vulvar vestibulitis; Vulvodynia; Vulvovaginal candidiasis

Indexed keywords

ESTROGEN; INTERLEUKIN 6; PROSTAGLANDIN E2; ZYMOSAN; CYCLOOXYGENASE 2;

ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CASE REPORT; COMPARATIVE STUDY; CONSTRUCT VALIDITY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FIBROBLAST; FUNGAL STRAIN; HUMAN; IMMUNE RESPONSE; INFLAMMATORY PAIN; LOCALIZED PROVOKED VULVODYNIA; NONHUMAN; PAIN ASSESSMENT; PAIN MEASUREMENT; PAIN THRESHOLD; PATHOGENESIS; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SALPINGOOOPHORECTOMY; VULVODYNIA; CANDIDA; GENETICS; INFLAMMATION; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; STATISTICAL MODEL;

ADULT; CANDIDA; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; FIBROBLASTS; HUMANS; INFLAMMATION; INTERLEUKIN-6; LINEAR MODELS; PAIN MEASUREMENT; VULVODYNIA;

EID: 84964575882     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/01.j.pain.0000460320.95267.5d     Document Type: Article

References (72)

1. Arnold LD, Bachmann GA, Rosen R, Kelly S, Rhoads GG. Vulvodynia: characteristics and associations with comorbidities and quality of life. Obstet Gynecol 2006;107:617-24.
2. Ashley C, Morhart M, Rennie R, Ziola B. Release of Candida albicans yeast antigens upon interaction with human neutrophils in vitro. J Med Microbiol 1997;46:747-55.
3. Baglole CJ,Reddy SY, Pollock SJ, FeldonSE, SimePJ, Smith TJ, PhippsRP. Isolation and phenotypic characterization of lung fibroblasts. Methods Mol Med 2005;117:115-27.
4. Bergeron S, Binik YM, Khalife S, Pagidas K, Glazer HI. Vulvar vestibulitis syndrome: reliability of diagnosis and evaluation of current diagnostic criteria. Obstet Gynecol 2001;98:45-51.
5. Bohm-Starke N, Hilliges M, Brodda-Jansen G, Rylander E, Torebjork E. Psychophysical evidence of nociceptor sensitization in vulvar vestibulitis syndrome. PAIN 2001;94:177-83.
6. Bourgeois C, Kuchler K. Fungal pathogens-A sweet and sour treat for tolllike receptors. Front Cell Infect Microbiol 2012;2:142.
7. Brown CJ, Wong M, Davis CC, Kanti A, Zhou X, Forney LJ. Preliminary characterization of the normal microbiota of the human vulva using cultivation-independent methods. J Med Microbiol 2007;56:271-6.
8. Cavalli F, Mucci MP, Cociancich L, Micheli W, Bacarini L, Cisternino M. Prostaglandin E2 liberation in the synovial fluid induced by organoiodinated contrast media. Interrelations with the genesis of postarthrographic pain [in Italian]. Radiologia Med 1987;74:512-5.
9. Chaban B, Links MG, Jayaprakash TP, Wagner EC, Bourque DK, Lohn Z, Albert AY, van Schalkwyk J, Reid G, Hemmingsen SM, Hill JE, Money DM. Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle. Microbiome 2014;2:23.
10. Chaffin WL. Candida albicans cell wall proteins. Microbiology and molecular biology reviews. Microbiol Mol Biol Rev 2008;72:495-544.
11. ChangHY, Chi JT,Dudoit S, Bondre C, van deRijn M, Botstein D, BrownPO. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 2002;99:12877-82.
12. Coggeshall RE, Tate S, Carlton SM. Differential expression of tetrodotoxin-resistant sodium channels Nav1.8 and Nav1.9 in normal and inflamed rats. Neurosci Lett 2004;355:45-8.
13. Cui JG, Holmin S, Mathiesen T, Meyerson BA, Linderoth B. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. PAIN 2000;88:239-48.
14. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992;107:660-4.
15. Danielsson D, Teigen PK, Moi H. The genital econiche: focus on microbiota and bacterial vaginosis. Ann N Y Acad Sci 2011;1230: 48-58.
16. Daymond TJ, Rowell FJ. Reduction of prostaglandin E2 concentrations in synovial fluid of patients suffering from rheumatoid arthritis following tiaprofenic acid or indomethacin treatment. Drugs 1988;35:S1:4-8.
17. Edwards RR, Doleys DM, Fillingim RB, Lowery D. Ethnic differences in pain tolerance: clinical implications in a chronic pain population. Psychosomatic Med 2001;63:316-23.
18. Elias JM. Technical considerations in immunocytochemistry. Cell Vis 1998;5:35-6.
19. Eliav E, Benoliel R, Herzberg U, Kalladka M, Tal M. The role of IL-6 and IL-1beta in painful perineural inflammatory neuritis. Brain Behav Immun 2009;23:474-84.
20. Eva LJ, Reid WM, MacLean AB, Morrison GD. Assessment of response to treatment in vulvar vestibulitis syndrome by means of the vulvar algesiometer. Am J Obstet Gynecol 1999;181:99-102.
21. Falgier C, Kegley S, Podgorski H, Heisel T, Storey K, Bendel CM, Gale CA. Candida species differ in their interactions with immature human gastrointestinal epithelial cells. Pediatr Res 2011;69:384-9.
22. Farmer MA, Taylor AM, Bailey AL, Tuttle AH, MacIntyre LC,Milagrosa ZE, Crissman HP, Bennett GJ, Ribeiro-da-Silva A, Binik YM, Mogil JS. Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia. Sci Transl Med 2011;3:101ra191.
23. Firestein GS, Alvaro-Gracia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990;144:3347-53.
24. Erratum appears in J Immunol 1990 Aug 1;145(3):1037 Note: Alvaro-Garcia JM [corrected to Alvaro-Gracia JM
25. Foster DC, Dworkin RH, Wood RW. Effects of intradermal foot and forearm capsaicin injections in normal and vulvodynia-afflicted women. PAIN 2005;117:128-36.
26. Foster DC, Kotok MB, Huang LS, Watts A, Oakes D, Howard FM, Stodgell CJ, Dworkin RH. The tampon test for vulvodynia treatment outcomes research: reliability, construct validity, and responsiveness. Obstet Gynecol 2009;113:825-32.
27. Foster DC, Piekarz KH, Murant TI, LaPoint R, Haidaris CG, Phipps RP. Enhanced synthesis of proinflammatory cytokines by vulvar vestibular fibroblasts: implications for vulvar vestibulitis. Am J obstet Gynecol 2007; 196(4):e341-348.
28. Fukuoka H, Kawatani M, Hisamitsu T, Takeshige C. Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat. Brain Res 1994;657:133-40.
29. Ghosh S, Howe N, Volk K, Tati S, Nickerson KW, Petro TM. Candida albicans cell wall components and farnesol stimulate the expression of both inflammatory and regulatory cytokines in the murine RAW264.7 macrophage cell line. FEMS Immunol Med Microbiol 2010;60:63-73.
30. Giesecke J, Reed BD, Haefner HK, Giesecke T, Clauw DJ, Gracely RH. Quantitative sensory testing in vulvodynia patients and increased peripheral pressure pain sensitivity. Obstet Gynecol 2004;104:126-33.
31. Goetsch MF, Lim JY, Caughey AB. Locating pain in breast cancer survivors experiencing dyspareunia: A randomized controlled trial. Obstet Gynecol 2014;123:1231-6.
32. Goetsch MF, Morgan TK, Korcheva VB, Li H, Peters D, Leclair CM. Histologic and receptor analysis of primary and secondary vestibulodynia and controls: A prospective study. Am J obstet Gynecol 2010;202(6): e611-618.
33. Gow NA, van de Veerdonk FL, Brown AJ, Netea MG. Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol 2012;10:112-22.
34. Granot M, Friedman M, Yarnitsky D, Tamir A, Zimmer EZ. Primary and secondary vulvar vestibulitis syndrome: systemic pain perception and psychophysical characteristics. Am J Obstet Gynecol 2004;191:138-42.
35. Harlow BL, Wise LA, Stewart EG. Prevalence and predictors of chronic lower genital tract discomfort. Am J Obstet Gynecol 2001;185:545-50.
36. Klis FM, Boorsma A, De Groot PW. Cell wall construction in Saccharomyces cerevisiae. Yeast 2006;23:185-202.
37. Koumas L, King AE, Critchley HO, Kelly RW, Phipps RP. Fibroblast heterogeneity: existence of functionally distinct Thy 1(1) and Thy 1(-) human female reproductive tract fibroblasts. Am J Pathol 2001;159:925-35.
38. Latge JP. Tasting the fungal cell wall. Cell Microbiol 2010;12:863-72.
39. LeclairCM, Goetsch MF, Korcheva VB, Anderson R, Peters D, Morgan TK. Differences in primary compared with secondary vestibulodynia by immunohistochemistry. Obstetr Gynecol 2011;117:1307-13.
40. Lev-Sagie A,Nyirjesy P, TarangeloN,Bongiovanni AM,BayerC, Linhares IM, Giraldo PC, Ledger WJ, Witkin SS. Hyaluronan in vaginal secretions: association with recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 2009;201:206-5.
41. Li M, Chen Q, Shen Y, Liu W. Candida albicans phospholipomannan triggers inflammatory responses of human keratinocytes through Toll-like receptor 2. Exp Dermatol 2009;18:603-10.
42. Lin CR, Amaya F, Barrett L, Wang H, Takada J, Samad TA, Woolf CJ. Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity. J Pharmacol Exp Ther 2006;319:1096-103.
43. Mann MS, Kaufman RH, Brown D, Adam E. Vulvar vestibulitis: significant clinical variables and treatment outcome. Obstet Gynecol 1992;79:122-5.
44. Meana M, Binik YM, Khalife S, Cohen DR. Biopsychosocial profile of women with dyspareunia. Obstet Gynecol 1997;90:583-9.
45. Mills C, Leblond D, Joshi S, Zhu C, Hsieh G, Jacobson P, Meyer M, Decker M. Estimating efficacy and drug ED50's using von Frey thresholds: impact of weber's law and log transformation. J Pain 2012;13:519-23.
46. Netea MG, Kullberg BJ. Epithelial sensing of fungal invasion. Cell Host Microbe 2010;8:219-20.
47. Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, Hoff B, VanHandelM, Andes D. Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 2007;51:510-20.
48. Nobile CJ, Nett JE, Hernday AD, Homann OR, Deneault JS, Nantel A, Andes DR, Johnson AD, Mitchell AP. Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol 2009;7:e1000133.
49. Nunns D, Mandal D. Psychological and psychosexual aspects of vulvar vestibulitis. Genitourin Med 1997;73:541-4.
50. Obreja O, Schmelz M, Poole S, Kress M. Interleukin-6 in combination with its soluble IL-6 receptor sensitises rat skin nociceptors to heat, in vivo. PAIN 2002;96:57-62.
51. Peckham BM, Maki DG, Patterson JJ, Hafez GR. Focal vulvitis: A characteristic syndrome and cause of dyspareunia. Features, natural history, and management. Am J Obstet Gynecol 1986;154:855-64.
52. Penington EC, Hutson JM. The cloacal plate: The missing link in anorectal and urogenital development. BJU Int 2002;89:726-32.
53. Penington EC, Hutson JM. The urethral plate-does it grow into the genital tubercle or within it? BJU Int 2002;89:733-9.
54. Perez-Garcia LA, Diaz-Jimenez DF, Lopez-Esparza A, Mora-Montes HM. Role of cell wall polysaccharides during recognition of Candida albicans by the innate immune system. Glycobiology 2011;1:1.
55. Ramirez-Ortiz ZG, Means TK. The role of dendritic cells in the innate recognition of pathogenic fungi (A. fumigatus, C. neoformans and C. albicans). [Review]. Virulence 2012;3:635-46.
56. Reinold H, Ahmadi S, Depner UB, Layh B, Heindl C, Hamza M, Pahl A, Brune K, Narumiya S, Muller U, Zeilhofer HU. Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest 2005;115:673-9.
57. Rodrigues CF, Silva S, Henriques M. Candida glabrata: A review of its features and resistance. Eur J clin Microbiol Infect Dis 2014;33:673-88.
58. Slominski A, Paus R, Schadendorf D. Melanocytes as "sensory" and regulatory cells in the epidermis. J Theor Biol 1993;164:103-20.
59. Smith TJ, Koumas L, Gagnon A, Bell A, Sempowski GD, Phipps RP, Sorisky A. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 2002;87:385-92.
60. Suram S, Silveira LJ, Mahaffey S, Brown GD, Bonventre JV, Williams DL, Gow NA, Bratton DL, Murphy RC, Leslie CC. Cytosolic phospholipase A(2)alpha and eicosanoids regulate expression of genes in macrophages involved in host defense and inflammation. PLoS One 2013;8:e69002.
61. TaffHT, Nett JE, Zarnowski R, Ross KM, Sanchez H, CainMT,Hamaker J, Mitchell AP, AndesDR. ACandida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog 2012;8:e1002848.
62. Tympanidis P, Casula MA, Yiangou Y, Terenghi G, Dowd P, Anand P. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur J Pain 2004;8:129-33.
63. Villar CC, Kashleva H, Mitchell AP, Dongari-Bagtzoglou A. Invasive phenotype of Candida albicans affects the host proinflammatory response to infection. Infect Immun 2005;73:4588-95.
64. Wendelschafer-Crabb G, Kennedy WR, Walk D. Morphological features of nerves in skin biopsies. J Neurol Sci 2006;242:15-21.
65. Witkin SS, Gerber S, Ledger WJ. Differential characterization of women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2002;187: 589-94.
66. Wolf J, Weinberger B, Arnold CR, Maier AB, Westendorp RG, Grubeck-Loebenstein B. The effect of chronological age on the inflammatory response of human fibroblasts. Exp Gerontol 2012;47:749-53.
67. Woodruff JD, Parmley TH. The Vulva. Atlas of gynecologic pathology. Philadelphia, PA: J.B Lippincott Co., 1988. p. 1.2-1.6.
68. Zanjani TM, Sabetkasaei M, Mosaffa N, Manaheji H, Labibi F, Farokhi B. Suppression of interleukin-6 by minocycline in a rat model of neuropathic pain. Eur J Pharmacol 2006;538:66-72.
69. Zhang Z, Zolnoun DA, Francisco EM, Holden JK, Dennis RG, Tommerdahl M. Altered central sensitization in subgroups of women with vulvodynia. Clin J Pain 2011;27:755-63.
70. Zhou X, Westman R, Hickey R, Hansmann MA, Kennedy C, Osborn TW, Forney LJ. Vaginal microbiota of women with frequent vulvovaginal candidiasis. Infect Immun 2009;77:4130-5.
71. Zolnoun D, Bair E, Essick G, Gracely R, Goyal V, Maixner W. Reliability and reproducibility of novel methodology for assessment of pressure pain sensitivity in pelvis. J Pain 2012;13:910-20.
72. Zolnoun D, Hartmann K, Lamvu G, As-Sanie S, Maixner W, Steege J. A conceptual model for the pathophysiology of vulvar vestibulitis syndrome. Obstetrical Gynecol Surv 2006;61:395-401.